About: Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
Creator	Botelho-Nevers, Élisabeth Delavenne, Xavier Diconne, Éric Lachand, Raphaël Launay, Manon Louf-Durier, Aurore Murgier, Martin Page, Dominique Perinel, Sophie Thierry, Guillaume Vermesch, Régine
Source	Medline; PMC
abstract	Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.
has issue date	2020-04-07(xsd:dateTime)
bibo:doi	10.1093/cid/ciaa394
bibo:pmid	32255489
has license	no-cc
sha1sum (hex)	de0fd7d47650a5408b1577b60b73baeb2b92f2e0
schema:url	https://doi.org/10.1093/cid/ciaa394
resource representing a document's title	Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
has PubMed Central identifier	PMC7184449
has PubMed identifier	32255489
schema:publication	Clin Infect Dis
resource representing a document's body	covid:de0fd7d47650a5408b1577b60b73baeb2b92f2e0#body_text
is schema:about of	named entity 'CONCENTRATIONS' named entity 'REGIMEN' named entity 'VARIOUS' named entity 'COVID-19' named entity 'STUDIES' named entity 'HYDROXYCHLOROQUINE' named entity 'Hydroxychloroquine' named entity 'Hydroxychloroquine' named entity 'Intensive Care Unit' named entity 'blood levels' named entity '85%' named entity 'therapeutic level' named entity 'multiple organ failure' named entity 'chloroquine' named entity 'hydroxychloroquine' named entity 'ECMO' named entity 'blood levels' named entity 'blood levels' named entity 'ICU' named entity 'HCQ' named entity 'cardiac toxicity' named entity 'adverse events' named entity 'HCQ' named entity 'HCQ' named entity 'prospective study' named entity 'France' named entity 'mechanically ventilated' named entity 'March 26' named entity 'HCQ' named entity 'rheumatoid arthritis' named entity 'therapeutic levels' named entity 'prolongation of the QT interval' named entity 'HCQ' named entity 'ethylenediamine tetraacetic acid' named entity 'arterial catheter' named entity 'volume of distribution' named entity 'Saint Etienne' named entity 'cardiac toxicity' named entity 'blood levels' named entity 'limit of quantification' named entity 'tissue tropism' named entity 'blood samples' named entity 'HCQ' named entity 'HCQ' named entity 'SARS-CoV-2' named entity 'assay' named entity 'Monte Carlo simulations' named entity 'COVID-19' named entity 'blood levels' named entity 'clinicaltrials.gov' named entity 'HCQ' named entity 'infection' named entity 'toxicity' named entity 'adsorption' named entity 'HCQ' named entity 'adverse events' named entity 'physiological' named entity 'chloroquine' named entity 'HCQ' named entity '3, 4' named entity 'COVID' named entity 'clinical trials' named entity 'zinc sulfate' named entity 'ICU' named entity 'Therapeutic drug monitoring' named entity 'HCQ' named entity 'cardiac toxicity' named entity 'HCQ' named entity 'March 30, 2020' named entity 'therapeutic level' named entity 'HCQ'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software